Biotech Values

[Biowatch]

Eli Lilly Will Cut the Price of Insulin
The company said it would cap the monthly out-of-pocket cost of the diabetes products at $35.

https://www.nytimes.com/2023/03/01/business/insulin-price-cap-eli-lilly.html

The drug maker Eli Lilly and Company said on Wednesday that it would significantly reduce the prices of several of its lifesaving insulin products that are used by diabetes patients and whose prices Lilly has repeatedly increased in the past.

Lilly also said it would cap at $35 a month what patients pay out of pocket for the drugmaker’s insulin products…

Lilly’s cuts to the products’ list prices, which will take effect over the course of this year, apply only to the company’s older insulin products.